

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 8.02792470 |
| 2 | positive regulation of catecholamine secretion (GO:0033605) | 6.32319069 |
| 3 | locomotory exploration behavior (GO:0035641) | 6.31504181 |
| 4 | exogenous drug catabolic process (GO:0042738) | 5.64721188 |
| 5 | exploration behavior (GO:0035640) | 5.21138483 |
| 6 | drug catabolic process (GO:0042737) | 4.89505982 |
| 7 | neuronal ion channel clustering (GO:0045161) | 4.55518075 |
| 8 | substrate-independent telencephalic tangential migration (GO:0021826) | 4.52808435 |
| 9 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 4.52808435 |
| 10 | sodium ion export (GO:0071436) | 4.38808682 |
| 11 | cell-cell junction maintenance (GO:0045217) | 4.37413204 |
| 12 | glutamate secretion (GO:0014047) | 4.33468649 |
| 13 | protein localization to synapse (GO:0035418) | 4.25057598 |
| 14 | arginine catabolic process (GO:0006527) | 4.15710251 |
| 15 | response to parathyroid hormone (GO:0071107) | 4.10022584 |
| 16 | regulation of cardioblast proliferation (GO:0003264) | 4.07607845 |
| 17 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 4.07607845 |
| 18 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.00477970 |
| 19 | behavioral response to nicotine (GO:0035095) | 3.97784493 |
| 20 | melanin biosynthetic process (GO:0042438) | 3.90413256 |
| 21 | glycogen catabolic process (GO:0005980) | 3.86435564 |
| 22 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.83972225 |
| 23 | regulation of synaptic vesicle transport (GO:1902803) | 3.81589565 |
| 24 | tachykinin receptor signaling pathway (GO:0007217) | 3.75746686 |
| 25 | mitochondrion transport along microtubule (GO:0047497) | 3.69544159 |
| 26 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.69544159 |
| 27 | cellular response to pH (GO:0071467) | 3.66862826 |
| 28 | positive regulation of neurotransmitter transport (GO:0051590) | 3.65508609 |
| 29 | glucan catabolic process (GO:0009251) | 3.61888952 |
| 30 | regulation of skeletal muscle contraction (GO:0014819) | 3.60287655 |
| 31 | positive regulation of amine transport (GO:0051954) | 3.60016609 |
| 32 | potassium ion export (GO:0071435) | 3.57927387 |
| 33 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.57770289 |
| 34 | cell migration in hindbrain (GO:0021535) | 3.57242964 |
| 35 | membrane repolarization during action potential (GO:0086011) | 3.53307613 |
| 36 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.52835679 |
| 37 | mannose metabolic process (GO:0006013) | 3.50486853 |
| 38 | cell junction maintenance (GO:0034331) | 3.49645603 |
| 39 | establishment of mitochondrion localization (GO:0051654) | 3.45121367 |
| 40 | regulation of synapse structural plasticity (GO:0051823) | 3.43608854 |
| 41 | urea metabolic process (GO:0019627) | 3.43123649 |
| 42 | urea cycle (GO:0000050) | 3.43123649 |
| 43 | relaxation of smooth muscle (GO:0044557) | 3.40504774 |
| 44 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.39334450 |
| 45 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.36682399 |
| 46 | arginine metabolic process (GO:0006525) | 3.36642867 |
| 47 | negative regulation of microtubule polymerization (GO:0031115) | 3.35043297 |
| 48 | membrane repolarization (GO:0086009) | 3.34837603 |
| 49 | plasma membrane repair (GO:0001778) | 3.34070434 |
| 50 | cellular potassium ion homeostasis (GO:0030007) | 3.34044649 |
| 51 | synaptic transmission, dopaminergic (GO:0001963) | 3.33952862 |
| 52 | peripheral nervous system neuron development (GO:0048935) | 3.33913364 |
| 53 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.33875383 |
| 54 | melanin metabolic process (GO:0006582) | 3.32266712 |
| 55 | secondary metabolite biosynthetic process (GO:0044550) | 3.30791838 |
| 56 | coronary vasculature morphogenesis (GO:0060977) | 3.30244380 |
| 57 | cellular polysaccharide catabolic process (GO:0044247) | 3.30058828 |
| 58 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 3.29582342 |
| 59 | carnitine shuttle (GO:0006853) | 3.27762409 |
| 60 | response to muscle activity (GO:0014850) | 3.26664181 |
| 61 | receptor recycling (GO:0001881) | 3.26193441 |
| 62 | membrane depolarization during action potential (GO:0086010) | 3.24164658 |
| 63 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.24012300 |
| 64 | regulation of catecholamine secretion (GO:0050433) | 3.23368592 |
| 65 | enteric nervous system development (GO:0048484) | 3.22164147 |
| 66 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.21251294 |
| 67 | L-phenylalanine catabolic process (GO:0006559) | 3.21251294 |
| 68 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.19596925 |
| 69 | regulation of autophagic vacuole assembly (GO:2000785) | 3.19591183 |
| 70 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.18320401 |
| 71 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.18275715 |
| 72 | nitrogen cycle metabolic process (GO:0071941) | 3.16944839 |
| 73 | detection of light stimulus involved in visual perception (GO:0050908) | 3.15482592 |
| 74 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.15482592 |
| 75 | fatty acid transmembrane transport (GO:1902001) | 3.14728750 |
| 76 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.14586778 |
| 77 | L-phenylalanine metabolic process (GO:0006558) | 3.14579949 |
| 78 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.14579949 |
| 79 | neurofilament cytoskeleton organization (GO:0060052) | 3.11158357 |
| 80 | skeletal muscle contraction (GO:0003009) | 3.10941215 |
| 81 | innervation (GO:0060384) | 3.10604841 |
| 82 | regulation of circadian sleep/wake cycle, sleep (GO:0045187) | 3.10487799 |
| 83 | regulation of circadian sleep/wake cycle (GO:0042749) | 3.10487799 |
| 84 | regulation of dopamine secretion (GO:0014059) | 3.09978213 |
| 85 | muscle filament sliding (GO:0030049) | 3.08547149 |
| 86 | actin-myosin filament sliding (GO:0033275) | 3.08547149 |
| 87 | dopamine receptor signaling pathway (GO:0007212) | 3.08310222 |
| 88 | neuromuscular process controlling posture (GO:0050884) | 3.08026325 |
| 89 | presynaptic membrane organization (GO:0097090) | 3.07397468 |
| 90 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.07310233 |
| 91 | polysaccharide catabolic process (GO:0000272) | 3.06223561 |
| 92 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.05940941 |
| 93 | cell communication by electrical coupling (GO:0010644) | 3.05048867 |
| 94 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.04812475 |
| 95 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.02555298 |
| 96 | regulation of cholesterol homeostasis (GO:2000188) | 3.01547721 |
| 97 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.01280408 |
| 98 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.00720676 |
| 99 | calcium ion-dependent exocytosis (GO:0017156) | 3.00228877 |
| 100 | multicellular organism reproduction (GO:0032504) | 2.98495593 |
| 101 | negative regulation of appetite (GO:0032099) | 2.98041413 |
| 102 | negative regulation of response to food (GO:0032096) | 2.98041413 |
| 103 | forebrain neuron differentiation (GO:0021879) | 2.95449634 |
| 104 | detection of temperature stimulus (GO:0016048) | 2.95160629 |
| 105 | neuron recognition (GO:0008038) | 2.92622914 |
| 106 | 4-hydroxyproline metabolic process (GO:0019471) | 2.92163220 |
| 107 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.92000650 |
| 108 | regulation of receptor binding (GO:1900120) | 2.91379046 |
| 109 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.90049981 |
| 110 | regulation of neurotransmitter secretion (GO:0046928) | 2.89799412 |
| 111 | alpha-linolenic acid metabolic process (GO:0036109) | 2.88694711 |
| 112 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.86718144 |
| 113 | respiratory system process (GO:0003016) | 2.86618123 |
| 114 | uterus development (GO:0060065) | 2.85973531 |
| 115 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.84916240 |
| 116 | negative regulation of macrophage differentiation (GO:0045650) | 2.84397725 |
| 117 | ganglion development (GO:0061548) | 2.84339735 |
| 118 | adhesion of symbiont to host cell (GO:0044650) | 2.84323288 |
| 119 | virion attachment to host cell (GO:0019062) | 2.84323288 |
| 120 | synaptic vesicle maturation (GO:0016188) | 2.84008631 |
| 121 | glycolytic process (GO:0006096) | 2.83427950 |
| 122 | axon extension (GO:0048675) | 2.83194513 |
| 123 | cellular sodium ion homeostasis (GO:0006883) | 2.80772522 |
| 124 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.78904842 |
| 125 | skeletal muscle adaptation (GO:0043501) | 2.77287394 |
| 126 | response to gravity (GO:0009629) | 2.76221050 |
| 127 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.75944069 |
| 128 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.75872148 |
| 129 | response to pH (GO:0009268) | 2.75797350 |
| 130 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.73728326 |
| 131 | axonal fasciculation (GO:0007413) | 2.73114128 |
| 132 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.72737502 |
| 133 | regulation of gonadotropin secretion (GO:0032276) | 2.72542305 |
| 134 | circadian sleep/wake cycle process (GO:0022410) | 2.72083660 |
| 135 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.71947140 |
| 136 | high-density lipoprotein particle remodeling (GO:0034375) | 2.71626426 |
| 137 | response to acidic pH (GO:0010447) | 2.71092556 |
| 138 | protein carboxylation (GO:0018214) | 2.71009887 |
| 139 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.71009887 |
| 140 | mesenchymal to epithelial transition (GO:0060231) | 2.70860537 |
| 141 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.69728514 |
| 142 | short-term memory (GO:0007614) | 2.69635175 |
| 143 | regulation of vacuole organization (GO:0044088) | 2.69492370 |
| 144 | suckling behavior (GO:0001967) | 2.68777562 |
| 145 | alanine transport (GO:0032328) | 2.68605734 |
| 146 | neuromuscular synaptic transmission (GO:0007274) | 2.68587311 |
| 147 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.68248788 |
| 148 | sexual reproduction (GO:0019953) | 2.67587818 |
| 149 | fructose metabolic process (GO:0006000) | 2.66929289 |
| 150 | positive regulation of gastrulation (GO:2000543) | 2.66349488 |
| 151 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.65107327 |
| 152 | protein hydroxylation (GO:0018126) | 2.64932248 |
| 153 | pyruvate metabolic process (GO:0006090) | 2.64849992 |
| 154 | adult walking behavior (GO:0007628) | 2.64653646 |
| 155 | negative regulation of metanephros development (GO:0072217) | 2.64412008 |
| 156 | dendritic spine morphogenesis (GO:0060997) | 2.62966963 |
| 157 | neuronal action potential propagation (GO:0019227) | 2.61824381 |
| 158 | striated muscle contraction (GO:0006941) | 2.61349988 |
| 159 | reverse cholesterol transport (GO:0043691) | 2.61033843 |
| 160 | body morphogenesis (GO:0010171) | 2.61025767 |
| 161 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.60525143 |
| 162 | protein polyglutamylation (GO:0018095) | 2.60469223 |
| 163 | aromatic amino acid family catabolic process (GO:0009074) | 2.60029624 |
| 164 | response to mercury ion (GO:0046689) | 2.59145185 |
| 165 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.58825644 |
| 166 | lysine catabolic process (GO:0006554) | 2.58126201 |
| 167 | lysine metabolic process (GO:0006553) | 2.58126201 |
| 168 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.58086435 |
| 169 | potassium ion homeostasis (GO:0055075) | 2.58031842 |
| 170 | kynurenine metabolic process (GO:0070189) | 2.56443176 |
| 171 | negative regulation of macroautophagy (GO:0016242) | 2.56119269 |
| 172 | negative regulation of response to extracellular stimulus (GO:0032105) | 2.56115431 |
| 173 | negative regulation of response to nutrient levels (GO:0032108) | 2.56115431 |
| 174 | hypothalamus development (GO:0021854) | 2.55467232 |
| 175 | axon regeneration (GO:0031103) | 2.55243416 |
| 176 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.53672472 |
| 177 | negative regulation of catecholamine secretion (GO:0033604) | 2.53538834 |
| 178 | myoblast fusion (GO:0007520) | 2.50190566 |
| 179 | phospholipid efflux (GO:0033700) | 2.49912133 |
| 180 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.48535233 |
| 181 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.48535233 |
| 182 | iron coordination entity transport (GO:1901678) | 2.46974052 |
| 183 | carnitine transmembrane transport (GO:1902603) | 2.46532986 |
| 184 | creatine metabolic process (GO:0006600) | 2.45707966 |
| 185 | positive regulation of lipid catabolic process (GO:0050996) | 2.45486735 |
| 186 | synaptic vesicle exocytosis (GO:0016079) | 2.44667392 |
| 187 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.44658745 |
| 188 | 2-oxoglutarate metabolic process (GO:0006103) | 2.44182888 |
| 189 | bile acid biosynthetic process (GO:0006699) | 2.43058023 |
| 190 | actin-mediated cell contraction (GO:0070252) | 2.41925851 |
| 191 | gluconeogenesis (GO:0006094) | 2.41849289 |
| 192 | positive regulation of fatty acid oxidation (GO:0046321) | 2.41787805 |
| 193 | cholesterol efflux (GO:0033344) | 2.41704447 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.47316285 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.26663586 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.95987975 |
| 4 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 3.50788901 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.06516670 |
| 6 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.87757676 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.70583211 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.68673998 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.41801825 |
| 10 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.32082651 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.26267364 |
| 12 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.03932811 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.95862727 |
| 14 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.95145721 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.88837593 |
| 16 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.86336123 |
| 17 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.85488308 |
| 18 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.82874975 |
| 19 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.82392682 |
| 20 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.81626681 |
| 21 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.81347938 |
| 22 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.79040259 |
| 23 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.79040259 |
| 24 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.78738665 |
| 25 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.77829780 |
| 26 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.71269389 |
| 27 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.66728418 |
| 28 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.65332122 |
| 29 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.60831922 |
| 30 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.58191830 |
| 31 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.57679339 |
| 32 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.57354920 |
| 33 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.54238395 |
| 34 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.51587132 |
| 35 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.50659236 |
| 36 | KDM2B_26808549_Chip-Seq_K562_Human | 1.50247650 |
| 37 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.49519853 |
| 38 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.47231210 |
| 39 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.47214010 |
| 40 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.46833049 |
| 41 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.45777062 |
| 42 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.43606956 |
| 43 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.43315747 |
| 44 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.41863417 |
| 45 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.41726410 |
| 46 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.38794633 |
| 47 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.36099163 |
| 48 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.34703186 |
| 49 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.34667994 |
| 50 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.31901294 |
| 51 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.29341739 |
| 52 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28118287 |
| 53 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.27633272 |
| 54 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.25597010 |
| 55 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.25038796 |
| 56 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.22238302 |
| 57 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.20939474 |
| 58 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.20508223 |
| 59 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.18933962 |
| 60 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.18760275 |
| 61 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.18578598 |
| 62 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.17993027 |
| 63 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.16992412 |
| 64 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.13621280 |
| 65 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.13580549 |
| 66 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.12436489 |
| 67 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.12295931 |
| 68 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.12147675 |
| 69 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11035074 |
| 70 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.08459979 |
| 71 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.08399310 |
| 72 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.07090912 |
| 73 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.06618658 |
| 74 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.06175001 |
| 75 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.05803570 |
| 76 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.05004462 |
| 77 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.02796027 |
| 78 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.01180009 |
| 79 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.00999600 |
| 80 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.00933624 |
| 81 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.00140475 |
| 82 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.00087492 |
| 83 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99855419 |
| 84 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.99403743 |
| 85 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.99403743 |
| 86 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.98759515 |
| 87 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.97785074 |
| 88 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97002331 |
| 89 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.96808701 |
| 90 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.96605538 |
| 91 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.96141912 |
| 92 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.95348457 |
| 93 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.93042655 |
| 94 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.92575392 |
| 95 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.91922869 |
| 96 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.91316644 |
| 97 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.90930903 |
| 98 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.90925261 |
| 99 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90553606 |
| 100 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.89426459 |
| 101 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.89328650 |
| 102 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.89109200 |
| 103 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89009005 |
| 104 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.88454854 |
| 105 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.87846176 |
| 106 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.87552937 |
| 107 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.87535889 |
| 108 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.87265345 |
| 109 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.85993154 |
| 110 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.85663908 |
| 111 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.85630170 |
| 112 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.85380529 |
| 113 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.85130783 |
| 114 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.84695864 |
| 115 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.84193464 |
| 116 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.84102654 |
| 117 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.83850055 |
| 118 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.83555055 |
| 119 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.83373092 |
| 120 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.83367393 |
| 121 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.83302217 |
| 122 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.82811822 |
| 123 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.82171128 |
| 124 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.82143240 |
| 125 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.81643024 |
| 126 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.81086315 |
| 127 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.80672666 |
| 128 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.80463811 |
| 129 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80455382 |
| 130 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.80455382 |
| 131 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.80297699 |
| 132 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.80022022 |
| 133 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.79615834 |
| 134 | P68_20966046_ChIP-Seq_HELA_Human | 0.79472307 |
| 135 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.79405757 |
| 136 | SA1_27219007_Chip-Seq_Bcells_Human | 0.78864996 |
| 137 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.78416594 |
| 138 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.78381277 |
| 139 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.77516397 |
| 140 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.77160883 |
| 141 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.76609099 |
| 142 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.76146307 |
| 143 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.76116926 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003123_paternal_imprinting | 6.35913306 |
| 2 | MP0003646_muscle_fatigue | 4.22623150 |
| 3 | MP0004145_abnormal_muscle_electrophysio | 3.84976665 |
| 4 | MP0004858_abnormal_nervous_system | 3.84734906 |
| 5 | MP0003787_abnormal_imprinting | 3.53321377 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 3.31638185 |
| 7 | MP0004036_abnormal_muscle_relaxation | 3.06497493 |
| 8 | MP0004233_abnormal_muscle_weight | 2.96228217 |
| 9 | MP0000749_muscle_degeneration | 2.95210044 |
| 10 | MP0003880_abnormal_central_pattern | 2.93579175 |
| 11 | MP0005360_urolithiasis | 2.91681618 |
| 12 | MP0000751_myopathy | 2.85928905 |
| 13 | MP0005085_abnormal_gallbladder_physiolo | 2.80090683 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.73075153 |
| 15 | MP0005083_abnormal_biliary_tract | 2.53602903 |
| 16 | MP0009840_abnormal_foam_cell | 2.44762984 |
| 17 | MP0004084_abnormal_cardiac_muscle | 2.44245513 |
| 18 | MP0005365_abnormal_bile_salt | 2.42502942 |
| 19 | MP0000747_muscle_weakness | 2.37541617 |
| 20 | MP0003315_abnormal_perineum_morphology | 2.35801168 |
| 21 | MP0002269_muscular_atrophy | 2.24839717 |
| 22 | MP0004130_abnormal_muscle_cell | 2.22569592 |
| 23 | MP0002090_abnormal_vision | 2.22344252 |
| 24 | MP0006276_abnormal_autonomic_nervous | 2.21135703 |
| 25 | MP0001188_hyperpigmentation | 2.16561754 |
| 26 | MP0003172_abnormal_lysosome_physiology | 2.11461648 |
| 27 | MP0003121_genomic_imprinting | 2.03503294 |
| 28 | MP0005410_abnormal_fertilization | 1.94985755 |
| 29 | MP0003191_abnormal_cellular_cholesterol | 1.93578771 |
| 30 | MP0003045_fibrosis | 1.93035980 |
| 31 | MP0010329_abnormal_lipoprotein_level | 1.91700332 |
| 32 | MP0002653_abnormal_ependyma_morphology | 1.90547839 |
| 33 | MP0002106_abnormal_muscle_physiology | 1.90480308 |
| 34 | MP0002063_abnormal_learning/memory/cond | 1.89820129 |
| 35 | MP0009046_muscle_twitch | 1.82125166 |
| 36 | MP0000759_abnormal_skeletal_muscle | 1.81149689 |
| 37 | MP0005620_abnormal_muscle_contractility | 1.77495951 |
| 38 | MP0005551_abnormal_eye_electrophysiolog | 1.74810633 |
| 39 | MP0008875_abnormal_xenobiotic_pharmacok | 1.74486879 |
| 40 | MP0009745_abnormal_behavioral_response | 1.73118913 |
| 41 | MP0004510_myositis | 1.72138760 |
| 42 | MP0001502_abnormal_circadian_rhythm | 1.70133948 |
| 43 | MP0005670_abnormal_white_adipose | 1.66417818 |
| 44 | MP0002572_abnormal_emotion/affect_behav | 1.65919616 |
| 45 | MP0002735_abnormal_chemical_nociception | 1.65365551 |
| 46 | MP0003329_amyloid_beta_deposits | 1.63317542 |
| 47 | MP0005409_darkened_coat_color | 1.63025201 |
| 48 | MP0002822_catalepsy | 1.58760875 |
| 49 | MP0008775_abnormal_heart_ventricle | 1.57705788 |
| 50 | MP0002163_abnormal_gland_morphology | 1.54114323 |
| 51 | MP0004087_abnormal_muscle_fiber | 1.51637901 |
| 52 | MP0010368_abnormal_lymphatic_system | 1.50075996 |
| 53 | MP0008961_abnormal_basal_metabolism | 1.49515279 |
| 54 | MP0005369_muscle_phenotype | 1.48399563 |
| 55 | MP0003252_abnormal_bile_duct | 1.47383335 |
| 56 | MP0001905_abnormal_dopamine_level | 1.45155032 |
| 57 | MP0004270_analgesia | 1.41975865 |
| 58 | MP0002882_abnormal_neuron_morphology | 1.41621079 |
| 59 | MP0000778_abnormal_nervous_system | 1.41298847 |
| 60 | MP0000343_altered_response_to | 1.39326641 |
| 61 | MP0002557_abnormal_social/conspecific_i | 1.38064082 |
| 62 | MP0002837_dystrophic_cardiac_calcinosis | 1.37988507 |
| 63 | MP0008004_abnormal_stomach_pH | 1.36675092 |
| 64 | MP0002332_abnormal_exercise_endurance | 1.35292537 |
| 65 | MP0003868_abnormal_feces_composition | 1.33927432 |
| 66 | MP0002909_abnormal_adrenal_gland | 1.30166454 |
| 67 | MP0001984_abnormal_olfaction | 1.30060261 |
| 68 | MP0003075_altered_response_to | 1.24388148 |
| 69 | MP0006072_abnormal_retinal_apoptosis | 1.23601144 |
| 70 | MP0000604_amyloidosis | 1.22254040 |
| 71 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.21388604 |
| 72 | MP0010386_abnormal_urinary_bladder | 1.20906343 |
| 73 | MP0004859_abnormal_synaptic_plasticity | 1.19836255 |
| 74 | MP0000920_abnormal_myelination | 1.19625128 |
| 75 | MP0005332_abnormal_amino_acid | 1.19237120 |
| 76 | MP0002118_abnormal_lipid_homeostasis | 1.16911376 |
| 77 | MP0005394_taste/olfaction_phenotype | 1.16595274 |
| 78 | MP0005499_abnormal_olfactory_system | 1.16595274 |
| 79 | MP0005319_abnormal_enzyme/_coenzyme | 1.16390626 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 1.15193170 |
| 81 | MP0002751_abnormal_autonomic_nervous | 1.13115731 |
| 82 | MP0005646_abnormal_pituitary_gland | 1.10087796 |
| 83 | MP0002736_abnormal_nociception_after | 1.08676479 |
| 84 | MP0000534_abnormal_ureter_morphology | 1.08117960 |
| 85 | MP0002638_abnormal_pupillary_reflex | 1.07371469 |
| 86 | MP0006082_CNS_inflammation | 1.06300757 |
| 87 | MP0001486_abnormal_startle_reflex | 1.05004328 |
| 88 | MP0002752_abnormal_somatic_nervous | 1.04204608 |
| 89 | MP0006138_congestive_heart_failure | 1.02955050 |
| 90 | MP0005058_abnormal_lysosome_morphology | 1.02585668 |
| 91 | MP0002089_abnormal_postnatal_growth/wei | 1.00770463 |
| 92 | MP0002229_neurodegeneration | 1.00600840 |
| 93 | MP0001968_abnormal_touch/_nociception | 1.00285460 |
| 94 | MP0003634_abnormal_glial_cell | 1.00046164 |
| 95 | MP0004134_abnormal_chest_morphology | 0.99641053 |
| 96 | MP0002184_abnormal_innervation | 0.99038917 |
| 97 | MP0005166_decreased_susceptibility_to | 0.97635439 |
| 98 | MP0008877_abnormal_DNA_methylation | 0.96632229 |
| 99 | MP0002972_abnormal_cardiac_muscle | 0.96445294 |
| 100 | MP0003631_nervous_system_phenotype | 0.95772126 |
| 101 | MP0002160_abnormal_reproductive_system | 0.91357230 |
| 102 | MP0000750_abnormal_muscle_regeneration | 0.90722281 |
| 103 | MP0002066_abnormal_motor_capabilities/c | 0.90246964 |
| 104 | MP0002733_abnormal_thermal_nociception | 0.89242877 |
| 105 | MP0003635_abnormal_synaptic_transmissio | 0.88534352 |
| 106 | MP0004883_abnormal_blood_vessel | 0.87782140 |
| 107 | MP0000955_abnormal_spinal_cord | 0.86733350 |
| 108 | MP0004185_abnormal_adipocyte_glucose | 0.85629317 |
| 109 | MP0008874_decreased_physiological_sensi | 0.85594704 |
| 110 | MP0003705_abnormal_hypodermis_morpholog | 0.85292016 |
| 111 | MP0006036_abnormal_mitochondrial_physio | 0.85270849 |
| 112 | MP0003656_abnormal_erythrocyte_physiolo | 0.84313508 |
| 113 | MP0002152_abnormal_brain_morphology | 0.84151860 |
| 114 | MP0002064_seizures | 0.84149084 |
| 115 | MP0002734_abnormal_mechanical_nocicepti | 0.84133745 |
| 116 | MP0000609_abnormal_liver_physiology | 0.83975543 |
| 117 | MP0001270_distended_abdomen | 0.83592122 |
| 118 | MP0001501_abnormal_sleep_pattern | 0.83476702 |
| 119 | MP0004811_abnormal_neuron_physiology | 0.82921297 |
| 120 | MP0004742_abnormal_vestibular_system | 0.81919751 |
| 121 | MP0002067_abnormal_sensory_capabilities | 0.80059575 |
| 122 | MP0001970_abnormal_pain_threshold | 0.80037541 |
| 123 | MP0002127_abnormal_cardiovascular_syste | 0.79339336 |
| 124 | MP0003690_abnormal_glial_cell | 0.78363931 |
| 125 | MP0000537_abnormal_urethra_morphology | 0.77970904 |
| 126 | MP0005666_abnormal_adipose_tissue | 0.77026577 |
| 127 | MP0003806_abnormal_nucleotide_metabolis | 0.76830954 |
| 128 | MP0001544_abnormal_cardiovascular_syste | 0.76770073 |
| 129 | MP0005385_cardiovascular_system_phenoty | 0.76770073 |
| 130 | MP0005257_abnormal_intraocular_pressure | 0.76767319 |
| 131 | MP0002078_abnormal_glucose_homeostasis | 0.76094049 |
| 132 | MP0003221_abnormal_cardiomyocyte_apopto | 0.76071809 |
| 133 | MP0004043_abnormal_pH_regulation | 0.75856479 |
| 134 | MP0004484_altered_response_of | 0.75764321 |
| 135 | MP0005379_endocrine/exocrine_gland_phen | 0.75470016 |
| 136 | MP0001440_abnormal_grooming_behavior | 0.75241614 |
| 137 | MP0003633_abnormal_nervous_system | 0.74036212 |
| 138 | MP0003890_abnormal_embryonic-extraembry | 0.73845589 |
| 139 | MP0002928_abnormal_bile_duct | 0.73131336 |
| 140 | MP0003879_abnormal_hair_cell | 0.72854017 |
| 141 | MP0002272_abnormal_nervous_system | 0.72651879 |
| 142 | MP0005334_abnormal_fat_pad | 0.72623202 |
| 143 | MP0008872_abnormal_physiological_respon | 0.71731777 |
| 144 | MP0008569_lethality_at_weaning | 0.71308736 |
| 145 | MP0005195_abnormal_posterior_eye | 0.71096037 |
| 146 | MP0000230_abnormal_systemic_arterial | 0.69611098 |
| 147 | MP0001986_abnormal_taste_sensitivity | 0.69530588 |
| 148 | MP0001963_abnormal_hearing_physiology | 0.69503840 |
| 149 | MP0000639_abnormal_adrenal_gland | 0.69311907 |
| 150 | MP0002971_abnormal_brown_adipose | 0.68067272 |
| 151 | MP0000538_abnormal_urinary_bladder | 0.63945689 |
| 152 | MP0005448_abnormal_energy_balance | 0.63677267 |
| 153 | MP0001919_abnormal_reproductive_system | 0.62643980 |
| 154 | MP0004885_abnormal_endolymph | 0.61389684 |
| 155 | MP0002998_abnormal_bone_remodeling | 0.60891425 |
| 156 | MP0005310_abnormal_salivary_gland | 0.60404268 |
| 157 | MP0003632_abnormal_nervous_system | 0.60188760 |
| 158 | MP0003119_abnormal_digestive_system | 0.59616886 |
| 159 | MP0001849_ear_inflammation | 0.56743554 |
| 160 | MP0005647_abnormal_sex_gland | 0.56650148 |
| 161 | MP0004924_abnormal_behavior | 0.56029606 |
| 162 | MP0005386_behavior/neurological_phenoty | 0.56029606 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 6.26670428 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 5.43539475 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 4.85929994 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.85929994 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.85929994 |
| 6 | Muscle fiber inclusion bodies (HP:0100299) | 4.69600834 |
| 7 | Myoglobinuria (HP:0002913) | 4.69512669 |
| 8 | Distal arthrogryposis (HP:0005684) | 4.62848811 |
| 9 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.48346779 |
| 10 | Muscle stiffness (HP:0003552) | 4.37769899 |
| 11 | Neurofibrillary tangles (HP:0002185) | 4.34923282 |
| 12 | Pheochromocytoma (HP:0002666) | 4.05924059 |
| 13 | Nemaline bodies (HP:0003798) | 4.02298165 |
| 14 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.98722083 |
| 15 | Congenital stationary night blindness (HP:0007642) | 3.95322908 |
| 16 | Cholecystitis (HP:0001082) | 3.86334039 |
| 17 | Abnormal gallbladder physiology (HP:0012438) | 3.86334039 |
| 18 | Disinhibition (HP:0000734) | 3.81623213 |
| 19 | Dysostosis multiplex (HP:0000943) | 3.75462333 |
| 20 | Myopathic facies (HP:0002058) | 3.72159758 |
| 21 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.68601349 |
| 22 | Hyporeflexia of lower limbs (HP:0002600) | 3.65724996 |
| 23 | Limb dystonia (HP:0002451) | 3.60691650 |
| 24 | Neuroendocrine neoplasm (HP:0100634) | 3.55960733 |
| 25 | Round ear (HP:0100830) | 3.49703977 |
| 26 | Myotonia (HP:0002486) | 3.45793970 |
| 27 | Apathy (HP:0000741) | 3.40273335 |
| 28 | Myokymia (HP:0002411) | 3.40056023 |
| 29 | Rhabdomyolysis (HP:0003201) | 3.39163663 |
| 30 | Abnormal pancreas size (HP:0012094) | 3.36383845 |
| 31 | Inappropriate behavior (HP:0000719) | 3.35055658 |
| 32 | Difficulty running (HP:0009046) | 3.32783147 |
| 33 | Type 1 muscle fiber predominance (HP:0003803) | 3.30122741 |
| 34 | Diminished motivation (HP:0000745) | 3.26494538 |
| 35 | Calf muscle hypertrophy (HP:0008981) | 3.24493922 |
| 36 | Vacuolated lymphocytes (HP:0001922) | 3.18041673 |
| 37 | Thoracic kyphosis (HP:0002942) | 3.15724488 |
| 38 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.15389605 |
| 39 | Complement deficiency (HP:0004431) | 3.15305034 |
| 40 | Visual hallucinations (HP:0002367) | 3.15104844 |
| 41 | Cerebral inclusion bodies (HP:0100314) | 3.11985542 |
| 42 | Focal dystonia (HP:0004373) | 3.06564524 |
| 43 | EMG: myopathic abnormalities (HP:0003458) | 3.06313150 |
| 44 | Systemic lupus erythematosus (HP:0002725) | 3.06037212 |
| 45 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.04263785 |
| 46 | Absent phalangeal crease (HP:0006109) | 2.97219748 |
| 47 | Polyphagia (HP:0002591) | 2.96689973 |
| 48 | Hepatoblastoma (HP:0002884) | 2.94390563 |
| 49 | Agitation (HP:0000713) | 2.93911107 |
| 50 | Ulnar deviation of the wrist (HP:0003049) | 2.91185297 |
| 51 | Potter facies (HP:0002009) | 2.89442140 |
| 52 | Facial shape deformation (HP:0011334) | 2.89442140 |
| 53 | Asymmetric septal hypertrophy (HP:0001670) | 2.86758846 |
| 54 | Postural instability (HP:0002172) | 2.80425307 |
| 55 | Muscle fiber splitting (HP:0003555) | 2.77792620 |
| 56 | Neuronal loss in central nervous system (HP:0002529) | 2.76541941 |
| 57 | Deep venous thrombosis (HP:0002625) | 2.73434214 |
| 58 | Hypercortisolism (HP:0001578) | 2.72396794 |
| 59 | Adrenal hypoplasia (HP:0000835) | 2.71890142 |
| 60 | Axonal loss (HP:0003447) | 2.70309726 |
| 61 | Metaphyseal dysplasia (HP:0100255) | 2.69528941 |
| 62 | Torticollis (HP:0000473) | 2.69172180 |
| 63 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.69061477 |
| 64 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.69061477 |
| 65 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.69061477 |
| 66 | Upper motor neuron abnormality (HP:0002127) | 2.66023951 |
| 67 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.65559061 |
| 68 | Xanthomatosis (HP:0000991) | 2.64849548 |
| 69 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.64399410 |
| 70 | Cholelithiasis (HP:0001081) | 2.62622140 |
| 71 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.61935245 |
| 72 | Central scotoma (HP:0000603) | 2.58445984 |
| 73 | Abnormal sex determination (HP:0012244) | 2.57592868 |
| 74 | Sex reversal (HP:0012245) | 2.57592868 |
| 75 | Loss of speech (HP:0002371) | 2.57214871 |
| 76 | Hypoalphalipoproteinemia (HP:0003233) | 2.56305213 |
| 77 | Cerebral hemorrhage (HP:0001342) | 2.55412160 |
| 78 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.55005512 |
| 79 | Mucopolysacchariduria (HP:0008155) | 2.55005512 |
| 80 | Anosmia (HP:0000458) | 2.53275175 |
| 81 | Dementia (HP:0000726) | 2.49279550 |
| 82 | Urinary urgency (HP:0000012) | 2.49009246 |
| 83 | Craniofacial dystonia (HP:0012179) | 2.47843695 |
| 84 | Abnormality of the Achilles tendon (HP:0005109) | 2.42619352 |
| 85 | Neonatal hypoglycemia (HP:0001998) | 2.41463974 |
| 86 | Abnormal finger flexion creases (HP:0006143) | 2.41032513 |
| 87 | Thoracolumbar scoliosis (HP:0002944) | 2.40830061 |
| 88 | Ankle clonus (HP:0011448) | 2.40095920 |
| 89 | Neoplasm of the adrenal cortex (HP:0100641) | 2.38824605 |
| 90 | Abnormal gallbladder morphology (HP:0012437) | 2.37442538 |
| 91 | Increased connective tissue (HP:0009025) | 2.36898132 |
| 92 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.33272113 |
| 93 | Neonatal onset (HP:0003623) | 2.32205496 |
| 94 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.31687147 |
| 95 | Anomalous pulmonary venous return (HP:0010772) | 2.31231917 |
| 96 | Amblyopia (HP:0000646) | 2.30371329 |
| 97 | Ulnar claw (HP:0001178) | 2.30127084 |
| 98 | Nuclear cataract (HP:0100018) | 2.29728996 |
| 99 | Difficulty climbing stairs (HP:0003551) | 2.28375062 |
| 100 | Achilles tendon contracture (HP:0001771) | 2.27460746 |
| 101 | Agnosia (HP:0010524) | 2.26687100 |
| 102 | Diastasis recti (HP:0001540) | 2.26619066 |
| 103 | Abnormality of the calf musculature (HP:0001430) | 2.25012597 |
| 104 | Retinal atrophy (HP:0001105) | 2.21797597 |
| 105 | Action tremor (HP:0002345) | 2.20772822 |
| 106 | Hypolipoproteinemia (HP:0010981) | 2.20574032 |
| 107 | Abnormality of the thoracic spine (HP:0100711) | 2.18348985 |
| 108 | Increased variability in muscle fiber diameter (HP:0003557) | 2.17787186 |
| 109 | Progressive cerebellar ataxia (HP:0002073) | 2.17462964 |
| 110 | Striae distensae (HP:0001065) | 2.16538320 |
| 111 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.15585629 |
| 112 | EMG: neuropathic changes (HP:0003445) | 2.15471303 |
| 113 | Macroglossia (HP:0000158) | 2.13984887 |
| 114 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.13430762 |
| 115 | Abnormality of the parathyroid morphology (HP:0011766) | 2.08650908 |
| 116 | Abnormal eating behavior (HP:0100738) | 2.07618612 |
| 117 | Gout (HP:0001997) | 2.07008415 |
| 118 | Intrahepatic cholestasis (HP:0001406) | 2.06051937 |
| 119 | Abnormality of complement system (HP:0005339) | 2.05620866 |
| 120 | Hypoventilation (HP:0002791) | 2.05423518 |
| 121 | Hypobetalipoproteinemia (HP:0003563) | 2.03654390 |
| 122 | Focal seizures (HP:0007359) | 2.03507490 |
| 123 | Hyperkalemia (HP:0002153) | 2.02421957 |
| 124 | Enlarged penis (HP:0000040) | 2.01722784 |
| 125 | Areflexia of lower limbs (HP:0002522) | 2.01409927 |
| 126 | Hyperthyroidism (HP:0000836) | 2.01138404 |
| 127 | Hyperlipoproteinemia (HP:0010980) | 1.99653576 |
| 128 | Epileptic encephalopathy (HP:0200134) | 1.98431598 |
| 129 | Cerebral hypomyelination (HP:0006808) | 1.98399616 |
| 130 | Turricephaly (HP:0000262) | 1.95527530 |
| 131 | Ventricular fibrillation (HP:0001663) | 1.95342508 |
| 132 | Cerebral aneurysm (HP:0004944) | 1.95143508 |
| 133 | J-shaped sella turcica (HP:0002680) | 1.94238343 |
| 134 | Febrile seizures (HP:0002373) | 1.93971223 |
| 135 | Fetal akinesia sequence (HP:0001989) | 1.93500567 |
| 136 | Abnormality of the pulmonary veins (HP:0011718) | 1.93363548 |
| 137 | Testicular neoplasm (HP:0010788) | 1.93122889 |
| 138 | Retinal dysplasia (HP:0007973) | 1.93055392 |
| 139 | Hyperammonemia (HP:0001987) | 1.92719243 |
| 140 | Mutism (HP:0002300) | 1.92643961 |
| 141 | Frequent falls (HP:0002359) | 1.91807036 |
| 142 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.91625431 |
| 143 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.91625431 |
| 144 | Failure to thrive in infancy (HP:0001531) | 1.91298756 |
| 145 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.90851772 |
| 146 | Atonic seizures (HP:0010819) | 1.90647067 |
| 147 | Supranuclear gaze palsy (HP:0000605) | 1.90218284 |
| 148 | Ketosis (HP:0001946) | 1.89375083 |
| 149 | Clumsiness (HP:0002312) | 1.88884920 |
| 150 | Glomerulonephritis (HP:0000099) | 1.88687861 |
| 151 | Deep palmar crease (HP:0006191) | 1.88321517 |
| 152 | Sensorimotor neuropathy (HP:0007141) | 1.87219509 |
| 153 | Disproportionate tall stature (HP:0001519) | 1.86702578 |
| 154 | Peripheral hypomyelination (HP:0007182) | 1.86001332 |
| 155 | Abnormality of the lower motor neuron (HP:0002366) | 1.85191645 |
| 156 | Abnormality of macular pigmentation (HP:0008002) | 1.84768453 |
| 157 | Hand muscle atrophy (HP:0009130) | 1.83180448 |
| 158 | Resting tremor (HP:0002322) | 1.81987481 |
| 159 | Truncal ataxia (HP:0002078) | 1.81716578 |
| 160 | Spastic gait (HP:0002064) | 1.81707863 |
| 161 | Calcaneovalgus deformity (HP:0001848) | 1.79924680 |
| 162 | Intention tremor (HP:0002080) | 1.79540214 |
| 163 | Spastic tetraplegia (HP:0002510) | 1.79075214 |
| 164 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.78841297 |
| 165 | Metaphyseal irregularity (HP:0003025) | 1.78694876 |
| 166 | Prolonged neonatal jaundice (HP:0006579) | 1.78602575 |
| 167 | Depression (HP:0000716) | 1.78471922 |
| 168 | Distal upper limb amyotrophy (HP:0007149) | 1.77707975 |
| 169 | Upper limb amyotrophy (HP:0009129) | 1.77707975 |
| 170 | Abnormality of binocular vision (HP:0011514) | 1.77661277 |
| 171 | Diplopia (HP:0000651) | 1.77661277 |
| 172 | Periauricular skin pits (HP:0100277) | 1.77367344 |
| 173 | Preauricular pit (HP:0004467) | 1.77367344 |
| 174 | Germ cell neoplasia (HP:0100728) | 1.77316326 |
| 175 | Foot dorsiflexor weakness (HP:0009027) | 1.77145027 |
| 176 | Bradykinesia (HP:0002067) | 1.75965997 |
| 177 | Male infertility (HP:0003251) | 1.74590585 |
| 178 | Epidermoid cyst (HP:0200040) | 1.74516478 |
| 179 | Scotoma (HP:0000575) | 1.73837995 |
| 180 | Abnormality of the gallbladder (HP:0005264) | 1.73740767 |
| 181 | Generalized tonic-clonic seizures (HP:0002069) | 1.73422689 |
| 182 | Stereotypic behavior (HP:0000733) | 1.73244130 |
| 183 | Palpitations (HP:0001962) | 1.72670770 |
| 184 | Increased cerebral lipofuscin (HP:0011813) | 1.72140702 |
| 185 | Abnormality of the aortic arch (HP:0012303) | 1.71864060 |
| 186 | Global brain atrophy (HP:0002283) | 1.71565158 |
| 187 | Rapidly progressive (HP:0003678) | 1.71303205 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PHKG1 | 4.24330338 |
| 2 | PHKG2 | 4.24330338 |
| 3 | OBSCN | 2.86863170 |
| 4 | NEK1 | 2.73785104 |
| 5 | MAP3K9 | 2.69950636 |
| 6 | MARK3 | 2.50697852 |
| 7 | MAP2K7 | 2.47619477 |
| 8 | STK16 | 2.42492776 |
| 9 | TTN | 2.23458467 |
| 10 | NME2 | 2.17237820 |
| 11 | LMTK2 | 2.13311125 |
| 12 | EPHA4 | 2.05932097 |
| 13 | SIK1 | 2.05584757 |
| 14 | ERN1 | 2.05180562 |
| 15 | MARK1 | 2.04861429 |
| 16 | NME1 | 2.02991142 |
| 17 | KSR2 | 1.97325319 |
| 18 | MAP3K7 | 1.90566835 |
| 19 | TGFBR2 | 1.90401831 |
| 20 | TRIB3 | 1.89978937 |
| 21 | MAP2K4 | 1.89136639 |
| 22 | TYRO3 | 1.83702508 |
| 23 | PKN2 | 1.82353762 |
| 24 | MAP2K3 | 1.81984047 |
| 25 | NTRK1 | 1.78152905 |
| 26 | RET | 1.72506310 |
| 27 | IRAK3 | 1.67471749 |
| 28 | PINK1 | 1.64982502 |
| 29 | CSNK1G2 | 1.63006943 |
| 30 | BCKDK | 1.61612925 |
| 31 | BRAF | 1.60905218 |
| 32 | MINK1 | 1.58982310 |
| 33 | MAPK12 | 1.56808431 |
| 34 | FLT3 | 1.53634486 |
| 35 | DYRK3 | 1.50405792 |
| 36 | MAPKAPK3 | 1.48717624 |
| 37 | SIK2 | 1.47797532 |
| 38 | PTK2 | 1.44575435 |
| 39 | GRK5 | 1.39075486 |
| 40 | PDK3 | 1.37660300 |
| 41 | PDK4 | 1.37660300 |
| 42 | RIPK1 | 1.35296357 |
| 43 | PAK6 | 1.34969015 |
| 44 | CASK | 1.34624117 |
| 45 | EEF2K | 1.34620808 |
| 46 | MARK2 | 1.34497046 |
| 47 | CSNK1G3 | 1.32011022 |
| 48 | CSNK1A1L | 1.31020987 |
| 49 | NTRK2 | 1.28115082 |
| 50 | DYRK2 | 1.27792130 |
| 51 | PIK3CG | 1.24625548 |
| 52 | MAP3K4 | 1.18226634 |
| 53 | NEK9 | 1.17827798 |
| 54 | CDK14 | 1.13628202 |
| 55 | NTRK3 | 1.13430202 |
| 56 | DDR2 | 1.12944425 |
| 57 | ADRBK2 | 1.12165097 |
| 58 | PRKCG | 1.10217931 |
| 59 | LATS2 | 1.05231878 |
| 60 | ABL2 | 1.04669688 |
| 61 | MAP2K6 | 1.01543331 |
| 62 | ARAF | 1.00968905 |
| 63 | ICK | 0.95821041 |
| 64 | CAMK4 | 0.94754886 |
| 65 | MAPK15 | 0.93504784 |
| 66 | MATK | 0.93426198 |
| 67 | CAMKK2 | 0.92560270 |
| 68 | PDK2 | 0.90265993 |
| 69 | STK38 | 0.88002393 |
| 70 | CAMK1 | 0.87503367 |
| 71 | RPS6KA2 | 0.87421823 |
| 72 | ZAP70 | 0.82717803 |
| 73 | ACVR1B | 0.81692825 |
| 74 | DAPK2 | 0.81603861 |
| 75 | DAPK3 | 0.81148155 |
| 76 | MOS | 0.80674956 |
| 77 | FGFR4 | 0.80042139 |
| 78 | CDK15 | 0.79488257 |
| 79 | CAMK1G | 0.79333842 |
| 80 | TAOK2 | 0.78629706 |
| 81 | CSNK1G1 | 0.78580411 |
| 82 | PRKAA1 | 0.77921777 |
| 83 | TAOK1 | 0.77465243 |
| 84 | PIM2 | 0.77289605 |
| 85 | CSF1R | 0.73938648 |
| 86 | MAP3K1 | 0.73540052 |
| 87 | DYRK1B | 0.73538015 |
| 88 | JAK1 | 0.71678266 |
| 89 | CDK18 | 0.71210141 |
| 90 | CAMKK1 | 0.70621745 |
| 91 | MAP3K13 | 0.70490631 |
| 92 | CDK11A | 0.69457107 |
| 93 | MAP2K1 | 0.69326977 |
| 94 | PRKAA2 | 0.68001372 |
| 95 | FRK | 0.67622774 |
| 96 | SGK2 | 0.62257291 |
| 97 | LIMK1 | 0.61607069 |
| 98 | CDK9 | 0.58986480 |
| 99 | TIE1 | 0.58608592 |
| 100 | PRKD3 | 0.58504952 |
| 101 | CDC42BPA | 0.58404700 |
| 102 | FGR | 0.57955682 |
| 103 | MAP3K2 | 0.57792484 |
| 104 | PDPK1 | 0.57225171 |
| 105 | PTK2B | 0.57215382 |
| 106 | PTK6 | 0.56984031 |
| 107 | PDK1 | 0.53104516 |
| 108 | MAPK11 | 0.52164515 |
| 109 | CAMK1D | 0.51942672 |
| 110 | DAPK1 | 0.51390466 |
| 111 | TYK2 | 0.49486589 |
| 112 | TNK2 | 0.49425131 |
| 113 | TGFBR1 | 0.49256665 |
| 114 | CSK | 0.48956254 |
| 115 | PRKACG | 0.48545024 |
| 116 | EPHB1 | 0.48320055 |
| 117 | RPS6KB1 | 0.48220753 |
| 118 | PAK1 | 0.47814851 |
| 119 | TESK1 | 0.47747362 |
| 120 | RPS6KC1 | 0.47595286 |
| 121 | RPS6KL1 | 0.47595286 |
| 122 | CSNK1A1 | 0.46590542 |
| 123 | FES | 0.46531197 |
| 124 | MAPK4 | 0.46212488 |
| 125 | AURKA | 0.46028678 |
| 126 | IRAK2 | 0.45651448 |
| 127 | CDK19 | 0.45089074 |
| 128 | MAP3K11 | 0.44086790 |
| 129 | FGFR2 | 0.43027555 |
| 130 | PDGFRA | 0.42424626 |
| 131 | JAK2 | 0.42153814 |
| 132 | FER | 0.42022900 |
| 133 | WNK1 | 0.39794397 |
| 134 | PRKG2 | 0.38965081 |
| 135 | BLK | 0.38505303 |
| 136 | RPS6KA6 | 0.38120781 |
| 137 | PKN1 | 0.36480320 |
| 138 | MAPK8 | 0.36363804 |
| 139 | GRK7 | 0.35988581 |
| 140 | CSNK1E | 0.35488811 |
| 141 | PRKACA | 0.35276226 |
| 142 | EPHA3 | 0.34914491 |
| 143 | CDK8 | 0.33305810 |
| 144 | EPHB2 | 0.32831564 |
| 145 | SGK3 | 0.32557421 |
| 146 | PRKCH | 0.32331369 |
| 147 | ALK | 0.32073871 |
| 148 | SGK494 | 0.31913440 |
| 149 | SGK223 | 0.31913440 |
| 150 | STK11 | 0.31898232 |
| 151 | ROCK1 | 0.31609722 |
| 152 | RPS6KA5 | 0.31391564 |
| 153 | DMPK | 0.31359939 |
| 154 | CDK5 | 0.31189563 |
| 155 | HCK | 0.31034839 |
| 156 | PRPF4B | 0.31029417 |
| 157 | INSRR | 0.30951440 |
| 158 | PRKCZ | 0.30651714 |
| 159 | WNK4 | 0.27762073 |
| 160 | CAMK2A | 0.27500791 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.38989726 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.29234270 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.90625489 |
| 4 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.44416204 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.36442787 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.34286335 |
| 7 | Gap junction_Homo sapiens_hsa04540 | 2.26729368 |
| 8 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.11889506 |
| 9 | Phagosome_Homo sapiens_hsa04145 | 1.94841949 |
| 10 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.90426042 |
| 11 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.81927643 |
| 12 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.80813427 |
| 13 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.78650414 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.68805874 |
| 15 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.68313157 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.67736872 |
| 17 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.67074698 |
| 18 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.66533460 |
| 19 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.64804816 |
| 20 | Bile secretion_Homo sapiens_hsa04976 | 1.64722167 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.61147197 |
| 22 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.58235384 |
| 23 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.55736657 |
| 24 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.53899679 |
| 25 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.53206470 |
| 26 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.50899204 |
| 27 | Carbon metabolism_Homo sapiens_hsa01200 | 1.50087161 |
| 28 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.47925435 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.47873577 |
| 30 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.47601738 |
| 31 | Cocaine addiction_Homo sapiens_hsa05030 | 1.42211870 |
| 32 | Long-term potentiation_Homo sapiens_hsa04720 | 1.41006324 |
| 33 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.39831245 |
| 34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.39367440 |
| 35 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.36357170 |
| 36 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.34925896 |
| 37 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.33873928 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.33075827 |
| 39 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.32049974 |
| 40 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.30138236 |
| 41 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.28602942 |
| 42 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.27489734 |
| 43 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.26852450 |
| 44 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.24585478 |
| 45 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.23991725 |
| 46 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.22264483 |
| 47 | Galactose metabolism_Homo sapiens_hsa00052 | 1.20741824 |
| 48 | Phototransduction_Homo sapiens_hsa04744 | 1.18606784 |
| 49 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.17428086 |
| 50 | Salmonella infection_Homo sapiens_hsa05132 | 1.16986089 |
| 51 | Axon guidance_Homo sapiens_hsa04360 | 1.15114885 |
| 52 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.11960921 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.11259480 |
| 54 | Circadian rhythm_Homo sapiens_hsa04710 | 1.10613777 |
| 55 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.09725978 |
| 56 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.05059410 |
| 57 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.04318000 |
| 58 | Long-term depression_Homo sapiens_hsa04730 | 1.02954447 |
| 59 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.02776610 |
| 60 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.02733947 |
| 61 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.01873782 |
| 62 | Parkinsons disease_Homo sapiens_hsa05012 | 1.01647021 |
| 63 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.99977027 |
| 64 | Insulin resistance_Homo sapiens_hsa04931 | 0.99479792 |
| 65 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.99242393 |
| 66 | ABC transporters_Homo sapiens_hsa02010 | 0.98809112 |
| 67 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.95359922 |
| 68 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.94411439 |
| 69 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.94185573 |
| 70 | GABAergic synapse_Homo sapiens_hsa04727 | 0.93343436 |
| 71 | Renin secretion_Homo sapiens_hsa04924 | 0.92420867 |
| 72 | Prion diseases_Homo sapiens_hsa05020 | 0.92209404 |
| 73 | Melanogenesis_Homo sapiens_hsa04916 | 0.92170236 |
| 74 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.91200090 |
| 75 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.89792665 |
| 76 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.89563556 |
| 77 | Salivary secretion_Homo sapiens_hsa04970 | 0.89022327 |
| 78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.86806737 |
| 79 | Alzheimers disease_Homo sapiens_hsa05010 | 0.86611628 |
| 80 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.86553285 |
| 81 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.83747584 |
| 82 | Olfactory transduction_Homo sapiens_hsa04740 | 0.83224325 |
| 83 | Circadian entrainment_Homo sapiens_hsa04713 | 0.81721186 |
| 84 | Insulin secretion_Homo sapiens_hsa04911 | 0.81623067 |
| 85 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.81079371 |
| 86 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.80764927 |
| 87 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.80445437 |
| 88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.79155353 |
| 89 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.78465244 |
| 90 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.77415201 |
| 91 | Peroxisome_Homo sapiens_hsa04146 | 0.77079303 |
| 92 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.76858934 |
| 93 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.76834500 |
| 94 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.76199218 |
| 95 | Sulfur relay system_Homo sapiens_hsa04122 | 0.75490583 |
| 96 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.75445038 |
| 97 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.75185854 |
| 98 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.74120602 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.72992747 |
| 100 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.72918825 |
| 101 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.72492204 |
| 102 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.71984443 |
| 103 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.71253976 |
| 104 | Endocytosis_Homo sapiens_hsa04144 | 0.68872634 |
| 105 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.68690677 |
| 106 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.67812736 |
| 107 | Tuberculosis_Homo sapiens_hsa05152 | 0.67198007 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66419667 |
| 109 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.64861413 |
| 110 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.64012785 |
| 111 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.63419898 |
| 112 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.63307613 |
| 113 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.62215680 |
| 114 | Morphine addiction_Homo sapiens_hsa05032 | 0.61994747 |
| 115 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.59844387 |
| 116 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.59627389 |
| 117 | Nicotine addiction_Homo sapiens_hsa05033 | 0.59469248 |
| 118 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.59002711 |
| 119 | Pertussis_Homo sapiens_hsa05133 | 0.58079573 |
| 120 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.58070102 |
| 121 | Apoptosis_Homo sapiens_hsa04210 | 0.58020137 |
| 122 | Malaria_Homo sapiens_hsa05144 | 0.57684131 |
| 123 | Mineral absorption_Homo sapiens_hsa04978 | 0.56148659 |
| 124 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55701906 |
| 125 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.54615089 |
| 126 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52082294 |
| 127 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.51626801 |
| 128 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.51569642 |
| 129 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.51307373 |
| 130 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.50188635 |
| 131 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.49843005 |
| 132 | Glioma_Homo sapiens_hsa05214 | 0.49187725 |
| 133 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.48280454 |
| 134 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47840052 |
| 135 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.47798650 |
| 136 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.46704661 |
| 137 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.46073393 |
| 138 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.45852072 |
| 139 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.45090073 |
| 140 | Lysosome_Homo sapiens_hsa04142 | 0.44399432 |
| 141 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.44332205 |
| 142 | Alcoholism_Homo sapiens_hsa05034 | 0.43720448 |
| 143 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.41948674 |
| 144 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41789388 |
| 145 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.41590877 |
| 146 | Huntingtons disease_Homo sapiens_hsa05016 | 0.41220987 |
| 147 | Lysine degradation_Homo sapiens_hsa00310 | 0.40622020 |
| 148 | Retinol metabolism_Homo sapiens_hsa00830 | 0.40113420 |
| 149 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.40028933 |
| 150 | Amoebiasis_Homo sapiens_hsa05146 | 0.39645878 |
| 151 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.39437255 |
| 152 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.39346389 |
| 153 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.39272502 |
| 154 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.38934821 |
| 155 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.38468184 |
| 156 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.38009872 |
| 157 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37757211 |
| 158 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.37455899 |
| 159 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.36422368 |
| 160 | Taste transduction_Homo sapiens_hsa04742 | 0.36284083 |
| 161 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.35874177 |
| 162 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.35752196 |
| 163 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.35574474 |

